Understanding Pemphigus vulgaris, a rare auto-immune disease that primarily affects the mouth. By: Joycelyn Eludoyin
Overview
Pemphigus vulgaris is a non-communicable auto-immune disease, that occurs when the
immune system attacks healthy, unproblematic proteins that are used for skin regeneration. This
paper will go over the causes, symptoms, and treatment for PV.
What is Pemphigus vulgaris (PV)?
As many other autoimmune diseases, Pemphigus vulgaris is extremely uncommon. 1-5
cases are reported per million people. Individuals diagnosed with PV will first see symptoms in
their mouth and throat, as blisters and sores will begin to form. The oral manifestations stem
from the immune system incorrectly sending autoantibodies to fight off structural proteins called,
desmoglein 3, which are responsible for maintaining the integrity of skin and mucus membranes.
When desmoglein 3 is met with these autoantibodies, skin cells start to separate and fill with
fluid or pus, which forms the painful blisters and lesions. Mucus membranes are primarily in the
mouth, nose, and respiratory region, which is why the oral region the first area to show
symptoms. PV can and is likely to spread to other regions of the body such as the scalp, back,
arms, etc. Blisters and sores are also prone to spread to infected areas.
Why is it important?
Pemphigus vulgaris is mainly found in individuals with southern Asian and Middle
Eastern/Mediterranean ethnic roots, such as Indians or Jewish populations. This is due to these
groups having unique HLA (Human Leukocyte Antigen) functions. Their HLA alleles mistake
normal and necessary autoimmune proteins as foreign, more often than those with different
genetic makeups. This is what causes desmoglein 3 to be repressed.
Middle aged groups ranging from 40-60 years old are more at risk for PV, due to
immunosenescence, the natural aging of the immune system. Because of these factors, people in
either or both of these demographics should be sure to report any sighting of oral blisters,
lesions, or general unease. Rapid weightloss is seen in those with PV, as eating becomes difficult
due to the oral injury, as well as decreased skin generation from the lack of desmoglein 3.
Pemphigus vulgaris can be fatal if left untreated.
It is also important to note other underlying causes of PV. Mass impoverishment is
prevalent in areas such as Southern Asia, which may contribute to the rate in which people is this
geographical location experience Pemphigus vulgaris. This can be supported through western
countries, such as Finland, having better living conditions, and .72 cases of PV, while India has
16 cases. *Correlation is not causation, but correlation nonetheless.*
Treatment
Unfortunately, researchers and health care providers do not fully understand PV. As of
today, there is no cure for the sickness. There are medicines such as rituximab that work to
deplete and suppress the autoantibodies that attack the desmoglein 3 cells. Others like
corticosteroids and steroid-sparing immunosuppressants work hand-in-hand to reduce the effects
of Pemphigus vulgaris. External care is also a method of treatment. This includes reducing
blisters and sores with ointments.
Closing Statements
Pemphigus vulgaris is a generally uncommon autoimmune disorder which attacks structural
mucus and skin proteins, and creates very harmful blisters and sores in the mouth. There is no
cure, but there are medicines and non-invasive methods to lessen severity. People with southern
Asian and Middle Eastern roots are more prone to PV, due to genetic factors.
Authors Note: I strongly believe that this sickness specifically is something that can go extinct, if enough research is
put into it. Current research shows that it is specific in certain demographics, which eliminates many factors that are
genetic or geographical. I want Pemphigus vulgaris to be more known, as it is something that anyone can be
af ected by.
Sources
NHS Choices. “Overview - Pemphigus Vulgaris.” NHS, 2019,
https://www.nhs.uk/conditions/pemphigus-vulgaris/. Accessed 13 July 2026.
Hopkins Medicine . (n.d.). Pemphigus Vulgaris [Review of Pemphigus Vulgaris].
Www.Hopkinsmedicine.Org. Retrieved July 13, 2026, from
https://www.hopkinsmedicine.org/health/conditions-and-diseases/pemphigus-vulgaris
Ingold, C. J., & Khan, M. A. (2021). Pemphigus Vulgaris. PubMed; StatPearls Publishing.
https://www.ncbi.nlm.nih.gov/books/NBK560860/
Nancy Garrick, D. D. (2017, April 11). Pemphigus. National Institute of Arthritis and
Musculoskeletal and Skin Diseases. https://www.niams.nih.gov/health-topics/pemphigus
About Pemphigus vulgaris (PV). (2026). Roche.Com.
https://medically.roche.com/global/en/microsites/about-pv.html
Porro, A. M., Seque, C. A., Ferreira, M. C. C., & Enokihara, M. M. S. S. (2019). Pemphigus
vulgaris. Anais Brasileiros de Dermatologia, 94(3), 264–278.
https://doi.org/10.1590/abd1806-4841.20199011
Comments
Post a Comment